Your browser doesn't support javascript.
loading
Pterostilbene inhibits hepatocellular carcinoma proliferation and HBV replication by targeting ribonucleotide reductase M2 protein.
Wang, Rui; Xu, Zhijian; Tian, Jiaping; Liu, Qian; Dong, Jingwen; Guo, Lijuan; Hai, Boning; Liu, Xia; Yao, Hangping; Chen, Zhi; Xu, Junjie; Zhu, Lijun; Chen, Haiyi; Hou, Tingjun; Zhu, Weiliang; Shao, Jimin.
Afiliación
  • Wang R; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Xu Z; Zhejiang University Cancer Center, Key Laboratory of Disease Proteomics of Zhejiang Province, Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education, Zhejiang University School of Medicine Hangzhou, China.
  • Tian J; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai, China.
  • Liu Q; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Dong J; Zhejiang University Cancer Center, Key Laboratory of Disease Proteomics of Zhejiang Province, Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education, Zhejiang University School of Medicine Hangzhou, China.
  • Guo L; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Hai B; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Liu X; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Yao H; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Chen Z; Department of Pathology & Pathophysiology, and Cancer Institute of The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Xu J; State Key Laboratory of Infectious Disease Diagnosis and Treatment, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Zhu L; State Key Laboratory of Infectious Disease Diagnosis and Treatment, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Chen H; Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Hou T; Key Laboratory of Pancreatic Disease of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
  • Zhu W; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University Hangzhou, China.
  • Shao J; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University Hangzhou, China.
Am J Cancer Res ; 11(6): 2975-2989, 2021.
Article en En | MEDLINE | ID: mdl-34249439
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China